← SynDRA
CIMLANOD
SynDRA canonical compound SYN0039765 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | nitric oxide donor |
|---|
| Indication | congestive heart failure |
|---|
| Disease area | cardiology |
|---|
All known targets
- GUCY1B1
- GUCY1A2
- GUCY1A1
- ITPR1
- ITPR2
- ITPR3
- NPR1
- GUCY1B2
Mechanisms of action (all sources)
- nitric oxide donor
- GUCY1B1 ACTIVATOR
- GUCY1A2 ACTIVATOR
- GUCY1A1 ACTIVATOR
- GUCY1B2 ACTIVATOR
Drug classes
- Antihypertensive Agents
- Cardiovascular Agents
- Indicators and Reagents
- Nitric Oxide Donors
- Vasodilator Agents
- Vasodilator
- Antioxidants
- Neuroprotective Agents
ATC classes
- ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
Cross-references
Synonyms
- BMS-986231
- CXL-1427
- N-Hydroxy-5-methylfuran-2-sulfonamide
- Cimlanod [USAN]
- UNII-2US4FK1EPV
- 2US4FK1EPV
- SCHEMBL15878610
- LIXKIXWSKOENAB-UHFFFAOYSA-N
- ZINC145617689
- 2-Furansulfonamide, N-hydroxy-5-methyl-
- cimlanodum
- RefChem:1081572
- DTXCID001718731
- N-Hydroxy-5-methyl-2-furansulfonamide
- Cimlanod [WHO-DD]
- Cimlanod (USAN/INN)
- CIMLANOD [INN]
- orb1707445
- CXL1427
- VPC33072
- BMS986231
- AKOS040741553
- N-hydroxy-5-methyl-furan-2-sulfonamide
- DA-62323
- MS-22948
- HY-118643
- CS-0067668
- D11407
- G17500
- T14967
- N-hydroxy-5-methylfuran-2-sulfonamide
Look up CIMLANOD in the interactive SynDRA portal →